[1] Fitzmaurice C, Akinyemiju T F, Al L F, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study[J]. JAMA Oncol, 2018, 4(11): 1553-1568.
[2] Hulscher J B, van Sandick J W, de Boer A G, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus[J]. N Engl J Med, 2002, 347(21): 1662- 1669.
[3] Low D E, Alderson D, Cecconello I, et al. International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG) [J]. Ann Surg, 2015, 262(2): 286-294.
[4] Biere S S, van Berge H M, Maas K W, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial[J]. Lancet, 2012, 379(9829): 1887-1892.
[5] Briez N, Piessen G, Bonnetain F, et al. Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial-the MIRO trial[J]. BMC Cancer, 2011, 11: 310.
[6] Sihag S, Wright C D, Wain J C, et al. Comparison of perioperative outcomes following open versus minimally invasive Ivor Lewis oesophagectomy at a single, highvolume centre[J]. Eur J Cardiothorac Surg, 2012, 42(3): 430-437.
[7] Mariette C, Markar S R, Dabakuyo-Yonli T S, et al. Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer[J]. N Engl J Med, 2019, 380(2): 152-162.
[8] Worrell S G, Bachman K C, Sarode A L, et al. Minimally invasive esophagectomy is associated with superior survival, lymphadenectomy and surgical margins: propensity matched analysis of the National Cancer Database[J]. Dis Esophagus, 2020, 1(1): 1-6.
[9] Kernstine K H, DeArmond D T, Karimi M, et al. The robotic, 2-stage, 3-field esophagolymphadenectomy[J]. J Thorac Cardiovasc Surg, 2004, 127(6): 1847-1849.
[10] van Hillegersberg R, Boone J, Draaisma W A, et al. First experience with robot-assisted thoracoscopic esophagolymphadenectomy for esophageal cancer[J]. Surg Endosc, 2006, 20(9): 1435-1439.
[11] Cuesta M A, Weijs T J, Bleys R L, et al. A new concept of the anatomy of the thoracic oesophagus: the mesooesophagus. Observational study during thoracoscopic esophagectomy[J]. Surg Endosc, 2015, 29(9): 2576- 2582.
[12] Sarkaria I S, Rizk N P, Goldman D A, et al. Early Quality of Life Outcomes After Robotic-Assisted Minimally Invasive and Open Esophagectomy[J]. Ann Thorac Surg, 2019, 108(3): 920-928.
[13] Meredith K, Huston J, Andacoglu O, et al. Safety and feasibility of robotic-assisted Ivor-Lewis esophagectomy[J]. Dis Esophagus, 2018, 31(7): 1-7.
[14] Guerra F, Vegni A, Gia E, et al. Early experience with totally robotic esophagectomy for malignancy. Surgical and oncological outcomes[J]. The International Journal of Medical Robotics and Computer Assisted Surgery, 2018, 14(3): e1902.
[15] ZHANG H, CHEN L, WANG Z, et al. The Learning Curve for Robotic McKeown Esophagectomy in Patients With Esophageal Cancer[J]. Ann Thorac Surg, 2018, 105(4): 1024-1030.
[16] Washington K, Watkins J R, Jay J, et al. Oncologic Resection in Laparoscopic Versus Robotic Transhiatal Esophagectomy[J]. JSLS, 2019, 23(2): 1-6.
[17] Wolff C S, Castillo S F, Larson D R, et al. Ivor Lewis approach is superior to transhiatal approach in retrieval of lymph nodes at esophagectomy[J]. Dis Esophagus, 2008, 21(4): 328-333.
[18] Lochowski M, Lochowska B, Kozak J. Transthoracic versus transhiatal esophagectomy-influence on patient survival[J]. Prz Gastroenterol, 2017, 12(2): 118-121.
[19] Giugliano D N, Berger A C, Rosato E L, et al. Total minimally invasive esophagectomy for esophageal cancer: approaches and outcomes[J]. Langenbecks Arch Surg, 2016, 401(6): 747-756.
[20] Dunn D H, Johnson E M, Morphew J A, et al. Robotassisted transhiatal esophagectomy: a 3-year singlecenter experience[J]. Dis Esophagus, 2013, 26(2): 159- 166.
[21] van der Sluis P C, Ruurda J P, van der Horst S, et al. Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial) [J]. Trials, 2012, 13: 230.
[22] van der Sluis P C, van der Horst S, May A M, et al. Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial[J]. Ann Surg, 2019, 269(4): 621-630.
[23] Yun J K, Chong B K, Kim H J, et al. Comparative outcomes of robot-assisted minimally invasive versus open esophagectomy in patients with esophageal squamous cell carcinoma: a propensity score-weighted analysis[J]. Dis Esophagus, 2019, 1(1): 1-8.
[24] ZHANG Y, HAN Y, GAN Q, et al. Early Outcomes of Robot-Assisted Versus Thoracoscopic-Assisted Ivor Lewis Esophagectomy for Esophageal Cancer: A Propensity Score-Matched Study[J]. Ann Surg Oncol, 2019, 26(5): 1284-1291.
[25] Chao Y K, Wen Y W, Chuang W Y, et al. Transition from video-assisted thoracoscopic to robotic esophagectomy: a single surgeon’s experience[J]. Dis Esophagus, 2020, 33(2): 1-8.
[26] CHAO Y K, LI Z G, WEN Y W, et al. Robotic-assisted Esophagectomy vs Video-Assisted Thoracoscopic Esophagectomy (REVATE): study protocol for a randomized controlled trial[J]. Trials, 2019, 20(1): 346.
[27] Surgical-teams HCCV.
[C]. https://cmrsurgical.com/ versius/surgical-teams/.
[28] Van Boxel G I, Kingma B F, Voskens F J, et al. Roboticassisted minimally invasive esophagectomy: past, present and future[J]. J Thorac Dis, 2020, 12(2): 54-62.
[29] JIANG F, JIANG Y, ZHI H, et al. Artificial intelligence in healthcare: past, present and future[J]. Stroke Vasc Neurol, 2017, 2(4): 230-243.
[30] Fujiwara H , Shiozaki A , Konishi H , et al. Transmediastinal approach for esophageal cancer: A new trend toward radical surgery[J]. Asian J Endosc Surg, 2019, 12(1): 30-36.
[31] Chiu P, Ng S, Au S. Transcervical minimally invasive esophagectomy using da Vinci(R) SP Surgical System: a feasibility study in cadaveric model[J]. Surg Endosc, 2019, 33(5): 1683-1686.